StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > LinkedIn yesterday

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Nov 22, 2022 12:43pm

85 Views

Post# 35119133

RE:RE:RE:RE:RE:LinkedIn yesterday

sorry I point out all the bs with this company

i guess it hurts the bs pump

Nailbiter2 wrote:

Liked2Think wrote:
I will stop when the sp of this "great company" goes above a sad and payhetic 10 cents

Nailbiter2 wrote: The post is forwarded to other linkedin links and eventually shows up on the company site.

Liked2Think wrote: And how many people follow their LinkedIn page?